Primarily opinions of the safety of short-course chemotherapy formula of 2SRH/4RH for anti-tuberculosis
- Author:
Thuy Thi Bich Tran
- Publication Type:Journal Article
- Keywords:
tuberculosis
- MeSH:
Tuberculosis;
drug therapy;
therapeutics;
Pharmaceutical Preparations;
Safety
- From:Journal of Medical and Pharmaceutical Information
2001;(11):25-28
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
Study on the security of the anti-tuberculosis, 40 TB patients had been treated by the short course therapy (2SRHZ/ 4RH) according to DOTS (Directly Observed Therapy Short- course) during 1998 in the hospital 74. All (100%) are cured as result, only 2 of them had been prolonged 1 months in the first phase. The value of SGOT, SGPT changed but no chronic significant. In 5 patients with liver diseases (viral hepatitis, cirrhosis), the value of these enzymes increased at the second month and decreased step-by- step to the normal. The author concluded that this is a safe short-course therapy, even in the patients with liver disease if to abide by DOTS and to combine with the liver protective drugs
